Myalgic encephalitis: Difference between revisions
Ossip Groth (talk | contribs) (Created page with "{{tp|p=37509075|t=2023. Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.|pdf=|usr=}}{{37509075}} {{tp|p=34831634|t=2021. Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP(2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.|pdf=|usr=}}{{34831634}} {{tp|p=34682454|t=2021. Potential Implications of Mammalia...") |
Ossip Groth (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{tp|p=27099524|t=2016. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome.|pdf=|usr=}}{{27099524}} | {{tp|p=27099524|t=2016. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome.|pdf=|usr=}}{{27099524}} | ||
{{tp|p=25574501|t=2014. Mechanisms of Myofascial Pain.|pdf=|usr=}}{{25574501}} | {{tp|p=25574501|t=2014. Mechanisms of Myofascial Pain.|pdf=|usr=}}{{25574501}} | ||
{{tp|p=37226227|t=2023. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.|pdf=|usr=}}{{37226227}} | |||
{{tp|p=35821534|t=2022. Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?|pdf=|usr=}}{{35821534}} | |||
{{tp|p=34540633|t=2021. A Comprehensive Update of the Current Understanding of Chronic Fatigue Syndrome.|pdf=|usr=}}{{34540633}} | |||
{{tp|p=36937672|t=2023. Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients.|pdf=|usr=}}{{36937672}} | |||
{{tp|p=36188362|t=2022. Multimodal MRI of myalgic encephalomyelitis/chronic fatigue syndrome: A cross-sectional neuroimaging study toward its neuropathophysiology and diagnosis.|pdf=|usr=}}{{36188362}} | |||
{{tp|p=35614970|t=2022. The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.|pdf=|usr=}}{{35614970}} | |||
{{tp|p=35046929|t=2021. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).|pdf=|usr=}}{{35046929}} | |||
{{tp|p=34326841|t=2021. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.|pdf=|usr=}}{{34326841}} | |||
{{tp|p=31394725|t=2019. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review.|pdf=|usr=}}{{31394725}} | |||
{{tp|p=31295930|t=2019. Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).|pdf=|usr=}}{{31295930}} | |||
{{tp|p=27727448|t=2017. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.|pdf=|usr=}}{{27727448}} | |||
{{tp|p=34682909|t=2021. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview.|pdf=|usr=}}{{34682909}} | |||
{{tp|p=35172836|t=2022. Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.|pdf=|usr=}}{{35172836}} | |||
{{tp|p=34266470|t=2021. The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP(2) and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.|pdf=|usr=}}{{34266470}} | |||
{{tp|p=33596913|t=2021. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome.|pdf=|usr=}}{{33596913}} | |||
{{tp|p=32727475|t=2020. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.|pdf=|usr=}}{{32727475}} | |||
{{tp|p=32353033|t=2020. A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques.|pdf=|usr=}}{{32353033}} | |||
{{tp|p=31796045|t=2019. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.|pdf=|usr=}}{{31796045}} | |||
{{tp|p=31671321|t=2019. Intra brainstem connectivity is impaired in chronic fatigue syndrome.|pdf=|usr=}}{{31671321}} | |||
{{tp|p=31014226|t=2019. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.|pdf=|usr=}}{{31014226}} | |||
{{tp|p=30035022|t=2018. Brain function characteristics of chronic fatigue syndrome: A task fMRI study.|pdf=|usr=}}{{30035022}} | |||
{{tp|p=31727160|t=2019. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.|pdf=|usr=}}{{31727160}} | |||
{{tp|p=37189737|t=2023. A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia.|pdf=|usr=}}{{37189737}} | |||
Latest revision as of 18:46, 29 January 2024
37509075 PDF 2023. Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.Template:37509075
34831634 PDF 2021. Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP(2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.Template:34831634
34682454 PDF 2021. Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review.Template:34682454
27099524 PDF 2016. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome.Template:27099524
25574501 PDF 2014. Mechanisms of Myofascial Pain.Template:25574501
37226227 PDF 2023. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.Template:37226227
35821534 PDF 2022. Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?Template:35821534
34540633 PDF 2021. A Comprehensive Update of the Current Understanding of Chronic Fatigue Syndrome.Template:34540633
36937672 PDF 2023. Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients.Template:36937672
36188362 PDF 2022. Multimodal MRI of myalgic encephalomyelitis/chronic fatigue syndrome: A cross-sectional neuroimaging study toward its neuropathophysiology and diagnosis.Template:36188362
35614970 PDF 2022. The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.Template:35614970
35046929 PDF 2021. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).Template:35046929
34326841 PDF 2021. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.Template:34326841
31394725 PDF 2019. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review.Template:31394725
31295930 PDF 2019. Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Template:31295930
27727448 PDF 2017. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.Template:27727448
34682909 PDF 2021. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview.Template:34682909
35172836 PDF 2022. Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.Template:35172836
34266470 PDF 2021. The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP(2) and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.Template:34266470
33596913 PDF 2021. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome.Template:33596913
32727475 PDF 2020. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.Template:32727475
32353033 PDF 2020. A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques.Template:32353033
31796045 PDF 2019. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.Template:31796045
31671321 PDF 2019. Intra brainstem connectivity is impaired in chronic fatigue syndrome.Template:31671321
31014226 PDF 2019. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.Template:31014226
30035022 PDF 2018. Brain function characteristics of chronic fatigue syndrome: A task fMRI study.Template:30035022
31727160 PDF 2019. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.Template:31727160
37189737 PDF 2023. A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia.Template:37189737